Literature DB >> 18381929

Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.

David Kent1, Michael Copley, Claudia Benz, Brad Dykstra, Michelle Bowie, Connie Eaves.   

Abstract

Understanding the intrinsic pathways that regulate hematopoietic stem cell (HSC) proliferation and self-renewal responses to external signals offers a rational approach to developing improved strategies for HSC expansion for therapeutic applications. Such studies are also likely to reveal new targets for the treatment of human myeloid malignancies because perturbations of the biological processes that control normal HSC self-renewal divisions are believed to drive the propagation of many of these diseases. Here, we review recent findings that point to the importance of using stringent functional criteria to define HSCs as cells with longterm repopulating activity and evidence that activation of the KIT receptor and many downstream effectors serve as major regulators of changing HSC proliferative and self-renewal behavior during development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381929     DOI: 10.1158/1078-0432.CCR-07-5134

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  75 in total

1.  KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

Authors:  Ling Zhao; Jan J Melenhorst; Lemlem Alemu; Martha Kirby; Stacie Anderson; Maggie Kench; Shelley Hoogstraten-Miller; Lauren Brinster; Yasuhiko Kamikubo; D Gary Gilliland; P Paul Liu
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

2.  Lamin B receptor regulates the growth and maturation of myeloid progenitors via its sterol reductase domain: implications for cholesterol biosynthesis in regulating myelopoiesis.

Authors:  Gayathri Subramanian; Pulkit Chaudhury; Krishnakumar Malu; Samantha Fowler; Rahul Manmode; Deepali Gotur; Monika Zwerger; David Ryan; Rita Roberti; Peter Gaines
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

3.  An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells.

Authors:  Hongmei Shen; Hui Yu; Paulina H Liang; Haizi Cheng; Richard XuFeng; Youzhong Yuan; Peng Zhang; Clayton A Smith; Tao Cheng
Journal:  Blood       Date:  2012-02-28       Impact factor: 22.113

4.  Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.

Authors:  Xingkui Xue; Nancy K Pech; W Christopher Shelley; Edward F Srour; Mervin C Yoder; Mary C Dinauer
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

5.  Foe turned friend: multiple functional roles attributable to hyper-activating stem cell factor receptor mutant in regeneration of the haematopoietic cell compartment.

Authors:  S Pati; O P Kalra; A Mukhopadhyay
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

6.  The ups and downs of p53 regulation in hematopoietic stem cells.

Authors:  Hussein A Abbas; Vinod Pant; Guillermina Lozano
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 7.  Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine.

Authors:  Guanqun Li; Xujun Liu; Qian Du; Mei Gao; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

8.  Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours.

Authors:  S Rodriguez; K Fadlalla; T Graham; B Tameru; C D Fermin; T Samuel
Journal:  J Comp Pathol       Date:  2012-01-30       Impact factor: 1.311

9.  Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.

Authors:  Yasuyuki Arai; Uimook Choi; Cristina I Corsino; Sherry M Koontz; Masaki Tajima; Colin L Sweeney; Mary A Black; Steven A Feldman; Mary C Dinauer; Harry L Malech
Journal:  Mol Ther       Date:  2018-03-10       Impact factor: 11.454

10.  Cloning of Soluble Human Stem Cell Factor in pET-26b(+) Vector.

Authors:  Salman Asghari; Mahmoud Shekari Khaniani; Masood Darabi; Sima Mansoori Derakhshan
Journal:  Adv Pharm Bull       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.